<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 17 Nov 2026 23:55:49 -0500--><rss version="2.0">
    <channel>
        <title>Rigel Pharmaceuticals, Inc. (RIGL) Press Releases</title>
        <link>https://www.rigel.com/news-media/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/rigel/files/rigel-logo-color-R_%281%29.png</url>
                <title>Rigel Pharmaceuticals, Inc. Logo</title>
                <link>https://www.rigel.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Rigel to Present at the Jefferies Global Healthcare Conference in London]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/452/rigel-to-present-at-the-jefferies-global-healthcare</link>
                <pubDate>Tue, 10 Nov 26 08:05:00 -0500</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/452/rigel-to-present-at-the-jefferies-global-healthcare</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Reports Third Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/451/rigel-reports-third-quarter-2026-financial-results</link>
                <pubDate>Thu, 05 Nov 26 16:01:00 -0500</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/451/rigel-reports-third-quarter-2026-financial-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Lower-Risk MDS at the 68th American Society of Hematology Annual Meeting and Exposition]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/450/rigel-announces-oral-presentation-of-phase-1b-data-for-r289</link>
                <pubDate>Wed, 04 Nov 26 09:15:00 -0500</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/450/rigel-announces-oral-presentation-of-phase-1b-data-for-r289</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Announces Conference Call and Webcast to Report Third Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/449/rigel-announces-conference-call-and-webcast-to-report-third</link>
                <pubDate>Thu, 29 Oct 26 08:05:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/449/rigel-announces-conference-call-and-webcast-to-report-third</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/448/rigel-highlights-new-gavreto-pralsetinib-data-across</link>
                <pubDate>Mon, 19 Oct 26 08:05:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/448/rigel-highlights-new-gavreto-pralsetinib-data-across</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel to Participate in Upcoming September Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/446/rigel-to-participate-in-upcoming-september-investor</link>
                <pubDate>Wed, 02 Sep 26 08:05:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/446/rigel-to-participate-in-upcoming-september-investor</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/445/rigel-announces-availability-of-veppanu-vepdegestrant</link>
                <pubDate>Thu, 13 Aug 26 08:05:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/445/rigel-announces-availability-of-veppanu-vepdegestrant</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Reports Second Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/444/rigel-reports-second-quarter-2026-financial-results</link>
                <pubDate>Tue, 04 Aug 26 16:01:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/444/rigel-reports-second-quarter-2026-financial-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/443/rigel-announces-conference-call-and-webcast-to-report</link>
                <pubDate>Tue, 28 Jul 26 08:05:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/443/rigel-announces-conference-call-and-webcast-to-report</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rigel.com/news-media/press-releases/detail/442/rigel-appoints-board-member-alison-l-hannah-m-d-as-chief</link>
                <pubDate>Wed, 01 Jul 26 08:05:00 -0400</pubDate>
                <guid isPermalink="true">https://www.rigel.com/news-media/press-releases/detail/442/rigel-appoints-board-member-alison-l-hannah-m-d-as-chief</guid>
                                                                            </item>
            </channel>
</rss>